About this trial
Statins have been used to low cholesterol to prevent and treat coronary artery diseases. It was also reported that statins could protect endothelial function and cardiac function during coronary artery bypass graft. The investigators recent found simvastatin reduced myocardial injury during noncoronary artery cardiac surgery in single medical center. The investigators further investigate that whether simvastatin can protect myocardium during noncoronary artery cardiac surgery with cardiopulmonary bypass and improve cardiac function with long term use postoperatively in two medical centers.
Eligibility criteria
Qualifiers
More than 18-year-old,
Congenital heart disease(not complex),
Isolated heart valve disease,
Disqualifiers
Coronary artery disease
Allergy for statins
Poor liver function,Hepatitis
Gestation women and Breast-feeding women
Trial design
Treatments tested in this trial
- simvastatin